Biopsy is a most common procedure which is used to remove a section of cells or tissue from the body. It is the most precise and accurate procedure for identifying or detecting malignancies. Biopsy can be categorized into excisional biopsy, incisional biopsy, aspiration biopsy and punch biopsy. Breast biopsy is also a procedure whereby the breast tissues are being removed to examine if there is any sort of indications of breast cancer. Breast biopsies are mostly conducted by minimal invasive biopsy system owing to reduction in pain and disfigurement. Breast biopsy marker is a piece of small tiny stainless steel or titanium marker which is used to identify the area where the breast tissue was removed. Br east biopsy marker has been proven to be safe and effective in biopsy procedure. According to American Institutes for Cancer Research report, over two million new cases were recorded U.S. in 2018.
The global breast biopsy markers market is expected to register substantial growth in the market owing to increase in prevalence of breast cancer among women and rising campaigns in creating awareness among women about breast cancer is likely to propel the growth of the breast biopsy markers market. In addition to this, rising reimbursement for the biopsy procedure and increasing demand for less invasive breast biopsy markers procedure is another factor adding to the growth of the breast biopsy markers market. However, there are certain limitations of breast biopsy markers. The breast biopsy markers may causes pain, rashes and allergies to the individuals. Moreover, the titanium used in breast biopsy markers may not be pure and may lead to contamination. All these complications impact the adoption of breast biopsy markers which may hamper the growth of the breast biopsy markers market. With the advancement in surgical procedure, the breast biopsy markers will foster the growth of the market. Currently, Vacuum-assisted core biopsy is gaining more popularity in breast biopsy markers market due to its safety and minimally invasive procedure. In addition to this, it provide accurate diagnosis and remove the lesion completely under real-time ultrasonic guidance.
Request For Report Sample: https://www.researchreportinsights.com/connectus/sample?flag=B&rep_id=53
The global breast biopsy markers market is segmented on the basis of material type, shape types and end user
Breast Biopsy Markers Market Segmentation by Material
Breast Biopsy Markers Market Segmentation by Shape
Breast Biopsy Markers Market Segmentation by End User
Ambulatory surgical centers
Cancer research laboratories
Geographically, breast biopsy markers market is categorized into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to hold the largest revenue share in breast biopsy markers market owing to advanced and early adoption of new technologies. According the US Breast Cancer statics, an estimate of 268,800 new cases is diagnosed in US in 2019. Increase in healthcare infractutre and government healthcare spending, the region is likely to contribute significant growth in the breast biopsy markers market. Europe accounts to have considerable share in breast biopsy markers due to increasing prevalence of the cancer and rising aging population. Asia Pacific seems to have increasing potential in breast biopsy markers market due to rising disposable income and increasing awareness among people about breast biopsy markers and breast cancer which as a result the overall breast biopsy markers will have increase in the market. Middle East and Africa shown to have less growth in the market owing to less adoption of new technologies and lack of proper healthcare facilities which may hinder the growth of the breast biopsy markers market.
Request For Report TOC: https://www.researchreportinsights.com/connectus/sample?flag=T&rep_id=53
Some of the key players leading in breast biopsy markers market are: Hologic Inc, Argon Medical Devices, Inc., Somatex Medical Technologies GmbH, Vigeo srl, Medsurge Ind Private Limited, TRA Medical Imaging, Cigna, Trivitron Healthcare, Johnson & Johnson Services, Inc, Biocept, Inc. Breast-Med, Inc., C.R. Bard, Inc. Leica Biosystems.